LSC
ASMB icon

Lyon Street Capital’s Assembly Biosciences ASMB Stock Holding History

Lyon Street Capital’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12,512
Closed -$5.89M – 47
2018
Q2 		$5.89M Buy
12,512
+952
+8% +$503K 2.09% 14
2018
Q1 		$6.82M Buy
11,560
+1,106
+11% +$686K 2.2% 13
2017
Q4 		$5.68M Sell
10,454
-2,000
-16% -$905K 1.89% 20
2017
Q3 		$5.22M Buy
12,454
+1,104
+10% +$338K 2.01% 22
2017
Q2 		$2.81M Buy
11,350
+8,842
+353% +$2.49M 1.13% 36
2017
Q1 		$767K Buy
+2,508
New +$615K 0.31% 42

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Lyon Street Capital's ASMB Position: Q3 2018 in Review

Lyon Street Capital sold out of Assembly Biosciences (ASMB) in Q3 2018, closing a stake of 12,512 shares — an estimated $5.89M sold.

Lyon Street Capital first reported a position in ASMB in Q1 2017 and held it in 6 quarters. The position peaked at $6.82M in Q1 2018. 113 funds tracked by Wall St. Rank hold ASMB as of Q3 2018.

  • Lyon Street Capital reported no remaining Assembly Biosciences position as of Q3 2018 after selling out during the quarter.
  • Lyon Street Capital sold 12,512 Assembly Biosciences shares in Q3 2018, an estimated $5.89M.
  • Lyon Street Capital first reported a position in Assembly Biosciences in Q1 2017 and held it in 6 quarters.
  • Lyon Street Capital's Assembly Biosciences position peaked at $6.82M in Q1 2018.
  • 113 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2018.

Based on Lyon Street Capital's 13F filing for Q3 2018, filed 14 Nov 2018.